Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. ((2-hexahydro-1(2h)-azocinyl)ethyl)guanidine
2. Guanethidine
3. Guanethidine Monosulfate
4. Guanethidine Sulfate (1:1)
5. Guanethidine Sulfate (1:2)
6. Guanethidine Sulfate (2:1)
7. Guanethidine Sulfate (2:1), 14c-labeled
8. Ismelin
9. Isobarin
10. Monosulfate, Guanethidine
11. Octadine
12. Oktadin
13. Sulfate, Guanethidine
1. 645-43-2
2. Guanethidine Monosulfate
3. Ismelin
4. Ismelin Sulfate
5. Guanethidine (sulfate)
6. Guanethidine Sulphae
7. 1-(2-(azocan-1-yl)ethyl)guanidine Sulfate
8. Guanethidine Monosulphate
9. 645-43-2 (sulfate)
10. 5uby8y002g
11. 2-[2-(azocan-1-yl)ethyl]guanidine;sulfuric Acid
12. Guanidine, (2-(hexahydro-1(2h)-azocinyl)ethyl)-, Sulfate (1:1)
13. Guanidine, [2-(hexahydro-1(2h)-azocinyl)ethyl]-, Sulfate (1:1)
14. Isobarin
15. Octadin
16. Octadine
17. Iporal
18. Guanetidin Sulfate
19. Guanethidinesulfate
20. 2-(octahydro-1-azocinyl)ethyl Guanidine Sulphate
21. Guanethidine Bisulfate
22. (2-(hexahydro-1(2h)-azocinyl)ethyl) Guanidine Hydrogen Sulfate
23. (2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine Sulfate (1:1)
24. Ismelin Sulfate (2:1)
25. Su 5864 Sulfate (1:1)
26. Chebi:51016
27. Nsc29863
28. Guanethidine Monosulfate [usan]
29. Einecs 211-442-0
30. Unii-5uby8y002g
31. Isomelin
32. Guanethidine Sulfate (1:1)
33. N-(2-guanidino Ethyl)heptamethylenimine Sulfate
34. Prestwick_249
35. Ismelin (tn)
36. [2-(hexahydro-1(2h)-azocinyl)ethyl]guanidine Sulfate (2:1)
37. Guanethidine Monosulfate [usan:usp]
38. Azocine, Sulfate (2:1)
39. Chembl1345
40. Schembl51039
41. Guanethidine Monosulphate Usp
42. Guanethidine Sulfate (jp17)
43. Spectrum1500323
44. Guanethidine Monosulfate (usp)
45. Schembl11658850
46. Hms501k21
47. (2-(hexahydro-(2h)-azocin-1-yl)ethyl)guanidinium Sulphate
48. Dtxsid20110019
49. Hms1568p16
50. Hms1920b19
51. Hms2091j05
52. Hms3749o19
53. Pharmakon1600-01500323
54. Methyltriallylammoniumbromide
55. Hy-b0800
56. Ac-479
57. Ccg-39688
58. Guanethidine Monosulfate [mi]
59. Mfcd00035403
60. Nsc757045
61. S5496
62. Akos015856688
63. Akos026750543
64. Wln: T8ntj A2myzum & 2wsqq
65. Cs-3931
66. Nsc-757045
67. Guanethidine Monosulfate [mart.]
68. Guanethidine Monosulfate [vandf]
69. Guanethidine Monosulfate [usp-rs]
70. Guanethidine Monosulfate [who-dd]
71. Ncgc00094691-01
72. Ncgc00094691-02
73. As-57397
74. .beta.-1-azacyclooctylethylguanidine Sulfate
75. Ft-0603504
76. Guanethidine Monosulfate [ep Impurity]
77. D04382
78. Esimil Component Guanethidine Monosulfate
79. Guanethidine Monosulfate [ep Monograph]
80. Guanethidine Monosulfate [usp Monograph]
81. [2-(octahydro-1-azocinyl)ethyl]guanidine Sulfate
82. Guanethidine Monosulfate Component Of Esimil
83. N-[2-(azocan-1-yl)ethyl]guanidine; Sulfuric Acid
84. Sr-05000001637
85. 1-[2-(azocan-1-yl)ethyl]guanidine (1/2h2so4)
86. Sr-05000001637-1
87. [2-(hexahydro-1(2h)-azocinyl)ethyl]guanidine Sulfate
88. N''-[2-(azocan-1-yl)ethyl]guanidine; Sulfuric Acid
89. Q27122277
90. N-[2-(hexahydro-1(2h)-azocinyl)ethyl]guanidine Sulfate
91. (2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine Sulfate (1:1).
92. (2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine Sulphate (1:1).
93. Guanidine, (2-(hexahydro-1(2h)-azocinyl)ethyl)-, Sulphate (1:1)
94. Guanethidine Monosulfate, United States Pharmacopeia (usp) Reference Standard
| Molecular Weight | 296.39 g/mol |
|---|---|
| Molecular Formula | C10H24N4O4S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 296.15182643 g/mol |
| Monoisotopic Mass | 296.15182643 g/mol |
| Topological Polar Surface Area | 151 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 248 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Sympatholytics
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)
Adrenergic Agents
Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)
API SUPPLIERS
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5070
Submission : 1983-07-26
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5122
Submission : 1983-08-26
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FDF Dossiers
Regulatory Info : DISCN
Registration Country : USA
Brand Name : GUANETHIDINE MONOSULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG SULFATE
Packaging :
Approval Date : 1985-03-26
Application Number : 86113
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : GUANETHIDINE MONOSULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG SULFATE
Packaging :
Approval Date : 1985-03-26
Application Number : 86114
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISMELIN
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG SULFATE
Packaging :
Approval Date : 1982-01-01
Application Number : 12329
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ISMELIN
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG SULFATE
Packaging :
Approval Date : 1982-01-01
Application Number : 12329
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
GUANETHIDINE MONOSULFATE; HYDROCHLOROTHIAZIDE
Brand Name : ESIMIL
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG;25MG
Packaging :
Approval Date : 1982-01-01
Application Number : 13553
Regulatory Info : DISCN
Registration Country : USA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
RLD : No
TE Code :
Brand Name : GUANETHIDINE MONOSULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG SULFATE
Approval Date : 1985-03-26
Application Number : 86113
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : GUANETHIDINE MONOSULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG SULFATE
Approval Date : 1985-03-26
Application Number : 86114
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : ISMELIN
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG SULFATE
Approval Date : 1982-01-01
Application Number : 12329
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : ISMELIN
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG SULFATE
Approval Date : 1982-01-01
Application Number : 12329
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
GUANETHIDINE MONOSULFATE; HYDROCHLOROTHIAZIDE
Brand Name : ESIMIL
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG;25MG
Approval Date : 1982-01-01
Application Number : 13553
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
Market Place
